Genetic Testing ServicesMarket Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, and Others), Disease (Cancer, Cardiovascular Diseases, Metabolic Diseases, and Other Diseases), Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others), and Geography
The genetic testing services market size is projected to reach US$ 12.48 billion by 2031 from US$ 3.86 billion in 2023. The market is expected to register a CAGR of 15.8% during 2023–2031. The g... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe genetic testing services market size is projected to reach US$ 12.48 billion by 2031 from US$ 3.86 billion in 2023. The market is expected to register a CAGR of 15.8% during 2023–2031.The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth. Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies. The quality and availability of genetic services may differ between high-income countries and low- to middle-income countries. For instance, in the US, Australia, Canada, the UK, and other European countries, genetic services are well-advanced, established, and extensive. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services that are offered in multiple settings still need improved systems of assessment. The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in the field of preventive medicine and clinical genetics into its portfolio. The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry. Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period. As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012–2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to correctly analyze and understand clinical data in fields such as radiology and cardiology. Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses. Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively. Service Provider -Based Insights Based on service provider, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. In 2023, the hospital-based laboratories segment held the largest share of the market and is anticipated to register the highest CAGR during 2023–2031. Hospital-based laboratories are genetic testing service providers that operate within a hospital setting. Hospital laboratories can be segmented by type of testing and staffed by personnel trained in particular specialties. For instance, some sections can focus on microbiology, hematology, chemistry, and blood banking. At the same time, some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry, and others can focus on surgical pathology and cytology, which are all linked with the investigation of cell and tissue structure. The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions. Seattle Children's Hospital in Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region provides comprehensive genetic testing and consultative services to healthcare workers and families. Their genetics laboratories consist of molecular genetics, cytogenetics, biochemical genetics, and a research and development laboratory devoted to bringing the most existing and specific research tests into the clinical field. Overall, these laboratories play a crucial role in helping to diagnose genetic disorders, guide treatment decisions, and improve patient outcomes. Centers for Disease Control and Prevention, the US Food and Drug Administration, the World Health Organization, and are among the primary and secondary sources referred to while preparing the genetic testing services market report. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Secondary Research 3.2 Primary Research 3.2.1 Hypothesis formulation: 3.2.2 Macro-economic factor analysis: 3.2.3 Data Triangulation: 3.2.4 Country level data: 4. Genetic Testing Services Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Genetic Testing Services Market – Key Market Dynamics 5.1 Key Market Drivers 5.1.1 Rising Prevalence of Genetic Diseases 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing 5.2 Market Restraints 5.2.1 Social and Ethical Implications of Genetic Testing 5.2.2 Affordability of Genetic Services 5.3 Market Opportunities 5.3.1 Untapped Emerging Markets in Developing Countries 5.4 Future Trends 5.4.1 Artificial Intelligence-Powered Genetic Testing 5.5 Impact Analysis: 6. Genetic Testing Services Market – Global Market Analysis 6.1 Genetic Testing Services Market Revenue (US$ Million), 2021–2031 6.2 Genetic Testing Services Market Forecast Analysis 7. Genetic Testing Services Market Analysis – by Type 7.1 Predictive Testing 7.1.1 Overview 7.1.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 7.2 Carrier Testing 7.2.1 Overview 7.2.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 7.3 Prenatal Testing 7.3.1 Overview 7.3.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 7.4 Newborn Screening 7.4.1 Overview 7.4.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 7.5 Diagnostic Genetic Testing 7.5.1 Overview 7.5.2 Diagnostic Genetic Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 7.6 Others 7.6.1 Overview 7.6.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 8. Genetic Testing Services Market Analysis – by Disease 8.1 Cancer 8.1.1 Overview 8.1.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 8.2 Cardiovascular Diseases 8.2.1 Overview 8.2.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 8.3 Metabolic Diseases 8.3.1 Overview 8.3.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 8.4 Other Diseases 8.4.1 Overview 8.4.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 9. Genetic Testing Services Market Analysis – by Service Provider 9.1 Hospital-Based Laboratories 9.1.1 Overview 9.1.2 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 9.2 Diagnostic Laboratories 9.2.1 Overview 9.2.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 9.3 Others 9.3.1 Overview 9.3.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10. Genetic Testing Services Market – Geographical Analysis 10.1 Overview 10.2 North America 10.2.1 North America Genetic Testing Services Market Overview 10.2.2 North America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.2.2.1 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Type 10.2.2.2 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease 10.2.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider 10.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country 10.2.3.1 US 10.2.3.1.1 Overview 10.2.3.2 United States: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.2.3.2.1 United States: Genetic Testing Services Market Breakdown, by Type 10.2.3.2.2 United States: Genetic Testing Services Market Breakdown, by Disease 10.2.3.2.3 United States: Genetic Testing Services Market Breakdown, by Service Provider 10.2.3.3 Canada 10.2.3.3.1 Overview 10.2.3.4 Canada: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.2.3.4.1 Canada: Genetic Testing Services Market Breakdown, by Type 10.2.3.4.2 Canada: Genetic Testing Services Market Breakdown, by Disease 10.2.3.4.3 Canada: Genetic Testing Services Market Breakdown, by Service Provider 10.2.3.5 Mexico 10.2.3.5.1 Overview 10.2.3.6 Mexico: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.2.3.6.1 Mexico: Genetic Testing Services Market Breakdown, by Type 10.2.3.6.2 Mexico: Genetic Testing Services Market Breakdown, by Disease 10.2.3.6.3 Mexico: Genetic Testing Services Market Breakdown, by Service Provider 10.3 Europe 10.3.1 Europe Genetic Testing Services Market Overview 10.3.2 Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.2.1 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Type 10.3.2.2 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease 10.3.2.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider 10.3.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country 10.3.3.1 UK 10.3.3.1.1 Overview 10.3.3.2 United Kingdom: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.2.1 United Kingdom: Genetic Testing Services Market Breakdown, by Type 10.3.3.2.2 United Kingdom: Genetic Testing Services Market Breakdown, by Disease 10.3.3.2.3 United Kingdom: Genetic Testing Services Market Breakdown, by Service Provider 10.3.3.3 Germany 10.3.3.3.1 Overview 10.3.3.4 Germany: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.4.1 Germany: Genetic Testing Services Market Breakdown, by Type 10.3.3.4.2 Germany: Genetic Testing Services Market Breakdown, by Disease 10.3.3.4.3 Germany: Genetic Testing Services Market Breakdown, by Service Provider 10.3.3.5 France 10.3.3.5.1 Overview 10.3.3.6 France: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.6.1 France: Genetic Testing Services Market Breakdown, by Type 10.3.3.6.2 France: Genetic Testing Services Market Breakdown, by Disease 10.3.3.6.3 France: Genetic Testing Services Market Breakdown, by Service Provider 10.3.3.7 Spain 10.3.3.7.1 Overview 10.3.3.8 Spain: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.8.1 Spain: Genetic Testing Services Market Breakdown, by Type 10.3.3.8.2 Spain: Genetic Testing Services Market Breakdown, by Disease 10.3.3.8.3 Spain: Genetic Testing Services Market Breakdown, by Service Provider 10.3.3.9 Italy 10.3.3.9.1 Overview 10.3.3.10 Italy: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.10.1 Italy: Genetic Testing Services Market Breakdown, by Type 10.3.3.10.2 Italy: Genetic Testing Services Market Breakdown, by Disease 10.3.3.10.3 Italy: Genetic Testing Services Market Breakdown, by Service Provider 10.3.3.11 Rest of Europe 10.3.3.11.1 Overview 10.3.3.12 Rest of Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3.12.1 Rest of Europe: Genetic Testing Services Market Breakdown, by Type 10.3.3.12.2 Rest of Europe: Genetic Testing Services Market Breakdown, by Disease 10.3.3.12.3 Rest of Europe: Genetic Testing Services Market Breakdown, by Service Provider 10.4 Asia Pacific 10.4.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.1.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Type 10.4.1.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease 10.4.1.3 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider 10.4.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country 10.4.2.1 China 10.4.2.1.1 Overview 10.4.2.2 China: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.2.1 China: Genetic Testing Services Market Breakdown, by Type 10.4.2.2.2 China: Genetic Testing Services Market Breakdown, by Disease 10.4.2.2.3 China: Genetic Testing Services Market Breakdown, by Service Provider 10.4.2.3 Japan 10.4.2.3.1 Overview 10.4.2.4 Japan: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.4.1 Japan: Genetic Testing Services Market Breakdown, by Type 10.4.2.4.2 Japan: Genetic Testing Services Market Breakdown, by Disease 10.4.2.4.3 Japan: Genetic Testing Services Market Breakdown, by Service Provider 10.4.2.5 India 10.4.2.5.1 Overview 10.4.2.6 India: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.6.1 India: Genetic Testing Services Market Breakdown, by Type 10.4.2.6.2 India: Genetic Testing Services Market Breakdown, by Disease 10.4.2.6.3 India: Genetic Testing Services Market Breakdown, by Service Provider 10.4.2.7 Australia 10.4.2.7.1 Overview 10.4.2.8 Australia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.8.1 Australia: Genetic Testing Services Market Breakdown, by Type 10.4.2.8.2 Australia: Genetic Testing Services Market Breakdown, by Disease 10.4.2.8.3 Australia: Genetic Testing Services Market Breakdown, by Service Provider 10.4.2.9 South Korea 10.4.2.9.1 Overview 10.4.2.10 South Korea: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.10.1 South Korea: Genetic Testing Services Market Breakdown, by Type 10.4.2.10.2 South Korea: Genetic Testing Services Market Breakdown, by Disease 10.4.2.10.3 South Korea: Genetic Testing Services Market Breakdown, by Service Provider 10.4.2.11 Rest of Asia Pacific 10.4.2.11.1 Overview 10.4.2.12 Rest of APAC: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.4.2.12.1 Rest of APAC: Genetic Testing Services Market Breakdown, by Type 10.4.2.12.2 Rest of APAC: Genetic Testing Services Market Breakdown, by Disease 10.4.2.12.3 Rest of APAC: Genetic Testing Services Market Breakdown, by Service Provider 10.5 Middle East and Africa 10.5.1 Middle East and Africa Genetic Testing Services Market Overview 10.5.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.5.2.1 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Type 10.5.2.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease 10.5.2.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider 10.5.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country 10.5.3.1 Saudi Arabia 10.5.3.1.1 Overview 10.5.3.2 Saudi Arabia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.5.3.2.1 Saudi Arabia: Genetic Testing Services Market Breakdown, by Type 10.5.3.2.2 Saudi Arabia: Genetic Testing Services Market Breakdown, by Disease 10.5.3.2.3 Saudi Arabia: Genetic Testing Services Market Breakdown, by Service Provider 10.5.3.3 South Africa 10.5.3.3.1 Overview 10.5.3.4 South Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.5.3.4.1 South Africa: Genetic Testing Services Market Breakdown, by Type 10.5.3.4.2 South Africa: Genetic Testing Services Market Breakdown, by Disease 10.5.3.4.3 South Africa: Genetic Testing Services Market Breakdown, by Service Provider 10.5.3.5 UAE 10.5.3.5.1 Overview 10.5.3.6 United Arab Emirates: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.5.3.6.1 United Arab Emirates: Genetic Testing Services Market Breakdown, by Type 10.5.3.6.2 United Arab Emirates: Genetic Testing Services Market Breakdown, by Disease 10.5.3.6.3 United Arab Emirates: Genetic Testing Services Market Breakdown, by Service Provider 10.5.3.7 Rest of Middle East & Africa 10.5.3.7.1 Overview 10.5.3.8 Rest of Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.5.3.8.1 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Type 10.5.3.8.2 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Disease 10.5.3.8.3 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Service Provider 10.6 South and Central America 10.6.1 South and Central America Genetic Testing Services Market Overview 10.6.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.6.2.1 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Type 10.6.2.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease 10.6.2.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider 10.6.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country 10.6.3.1 Brazil 10.6.3.1.1 Overview 10.6.3.2 Brazil: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.6.3.2.1 Brazil: Genetic Testing Services Market Breakdown, by Type 10.6.3.2.2 Brazil: Genetic Testing Services Market Breakdown, by Disease 10.6.3.2.3 Brazil: Genetic Testing Services Market Breakdown, by Service Provider 10.6.3.3 Argentina 10.6.3.3.1 Overview 10.6.3.4 Argentina: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.6.3.4.1 Argentina: Genetic Testing Services Market Breakdown, by Type 10.6.3.4.2 Argentina: Genetic Testing Services Market Breakdown, by Disease 10.6.3.4.3 Argentina: Genetic Testing Services Market Breakdown, by Service Provider 10.6.3.5 Rest of South & Central America 10.6.3.5.1 Overview 10.6.3.6 Rest of South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million) 10.6.3.6.1 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Type 10.6.3.6.2 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Disease 10.6.3.6.3 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Service Provider 11. Genetic Testing Services Market – Industry Landscape 11.1 Overview 11.2 Growth Strategies in Genetic Testing Services Market 11.3 Organic Growth Strategies 11.3.1 Overview 11.4 Inorganic Growth Strategies 11.4.1 Overview 12. Company Profiles 12.1 Eurofins Scientific SE 12.1.1 Key Facts 12.1.2 Business Description 12.1.3 Products and Services 12.1.4 Financial Overview 12.1.5 SWOT Analysis 12.1.6 Key Developments 12.2 Exact Sciences Corp 12.2.1 Key Facts 12.2.2 Business Description 12.2.3 Products and Services 12.2.4 Financial Overview 12.2.5 SWOT Analysis 12.2.6 Key Developments 12.3 Laboratory Corp of America Holdings 12.3.1 Key Facts 12.3.2 Business Description 12.3.3 Products and Services 12.3.4 Financial Overview 12.3.5 SWOT Analysis 12.3.6 Key Developments 12.4andMe Holding Co 12.4.1 Key Facts 12.4.2 Business Description 12.4.3 Products and Services 12.4.4 Financial Overview 12.4.5 SWOT Analysis 12.4.6 Key Developments 12.5 Ambry Genetics Corp 12.5.1 Key Facts 12.5.2 Business Description 12.5.3 Products and Services 12.5.4 Financial Overview 12.5.5 SWOT Analysis 12.5.6 Key Developments 12.6 Quest Diagnostics Inc 12.6.1 Key Facts 12.6.2 Business Description 12.6.3 Products and Services 12.6.4 Financial Overview 12.6.5 SWOT Analysis 12.6.6 Key Developments 12.7 Illumina Inc 12.7.1 Key Facts 12.7.2 Business Description 12.7.3 Products and Services 12.7.4 Financial Overview 12.7.5 SWOT Analysis 12.7.6 Key Developments 12.8 F. Hoffmann-La Roche Ltd 12.8.1 Key Facts 12.8.2 Business Description 12.8.3 Products and Services 12.8.4 Financial Overview 12.8.5 SWOT Analysis 12.8.6 Key Developments 12.9 NeoGenomics Inc 12.9.1 Key Facts 12.9.2 Business Description 12.9.3 Products and Services 12.9.4 Financial Overview 12.9.5 SWOT Analysis 12.9.6 Key Developments 12.10 Centogene NV 12.10.1 Key Facts 12.10.2 Business Description 12.10.3 Products and Services 12.10.4 Financial Overview 12.10.5 SWOT Analysis 12.10.6 Key Developments 12.11 Ancestry Genomics Inc 12.11.1 Key Facts 12.11.2 Business Description 12.11.3 Products and Services 12.11.4 Financial Overview 12.11.5 SWOT Analysis 12.11.6 Key Developments 12.12 Gene By Gene Ltd 12.12.1 Key Facts 12.12.2 Business Description 12.12.3 Products and Services 12.12.4 Financial Overview 12.12.5 SWOT Analysis 12.12.6 Key Developments 12.13 SIVOTEC BioInformatics LLC 12.13.1 Key Facts 12.13.2 Business Description 12.13.3 Products and Services 12.13.4 Financial Overview 12.13.5 SWOT Analysis 12.13.6 Key Developments 12.14 Progenesis 12.14.1 Key Facts 12.14.2 Business Description 12.14.3 Products and Services 12.14.4 Financial Overview 12.14.5 SWOT Analysis 12.14.6 Key Developments 12.15 Fulgent Genetics, Inc 12.15.1 Key Facts 12.15.2 Business Description 12.15.3 Products and Services 12.15.4 Financial Overview 12.15.5 SWOT Analysis 12.15.6 Key Developments 12.16 VERITAS INTERCONTINENTAL 12.16.1 Business Description 12.16.2 Products and Services 12.16.3 Financial Overview 12.16.4 SWOT Analysis 12.16.5 Key Developments 12.17 GeneDx, LLC 12.17.1 Key Facts 12.17.2 Business Description 12.17.3 Products and Services 12.17.4 Financial Overview 12.17.5 SWOT Analysis 12.17.6 Key Developments 13. Appendix 13.1 About The Insight Partners 13.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(carrier)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/25 10:26 153.16 円 166.17 円 201.34 円 |